Journal article

A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts

L McHugh, TA Seldon, RA Brandon, JT Kirk, A Rapisarda, AJ Sutherland, JJ Presneill, DJ Venter, J Lipman, MR Thomas, PMC Klein Klouwenberg, L van Vught, B Scicluna, M Bonten, OL Cremer, MJ Schultz, T van der Poll, TD Yager, RB Brandon

Plos Medicine | PUBLIC LIBRARY SCIENCE | Published : 2015

Abstract

Background: Systemic inflammation is a whole body reaction having an infection-positive (i.e., sepsis) or infection-negative origin. It is important to distinguish between these two etiologies early and accurately because this has significant therapeutic implications for critically ill patients. We hypothesized that a molecular classifier based on peripheral blood RNAs could be discovered that would (1) determine which patients with systemic inflammation had sepsis, (2) be robust across independent patient cohorts, (3) be insensitive to disease severity, and (4) provide diagnostic utility. The goal of this study was to identify and validate such a molecular classifier. Methods and Findings: ..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Center for Translational Molecular Medicine


Funding Acknowledgements

This work was funded through Australian Commercial-Ready Proof of Concept Grants (COM04345 to RBB DV MRT and CAU05428 to RBB DV MRT AJS) and a Commercialisation Australia Proof of Concept Grant (CAU06263 to RBB RAB) (http://www.business.gov.au/grants-and-assistance/Pages/default.aspx); and through the Center for Translational Molecular Medicine (http://www.ctmm.nl) project MARS (grant 04I-201 to TVDP MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.